eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant

The IND clearance supports a Phase 1/2/3 study to determine the safety and efficacy of their porcine-derived kidney in patients with dialysis-dependent ESKD, over the age of 50, who are currently on a transplant waitlist.

Read the full article » | Posted 09-15-2025

Related Articles

• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
• Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026